Search
Celcuity Inc
CELCAdd to Watchlist
87.760USD
-0.290-0.33%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
4.24BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Celcuity Inc is 8.83, ranking 53 out of 389 in the Biotechnology & Medical Research industry. The average price target is 108.00, with a high of 134.00 and a low of 94.00.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
160.636
Target Price
+83.04%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Celcuity Inc
CELC
12
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Celcuity Inc's price target?
Analysts forecast that Celcuity Inc's price target is USD 108.00, with the highest forecast at USD 134.00 and the lowest forecast at USD 94.00.
How have Celcuity IncCELC's recent earnings per share performed?
The market expectation was USD -0.97, while Celcuity IncCELC's earnings per share (EPS) for the previous quarter was USD -0.97. EPS for the next quarter is expected at USD -1.11.
What is the analyst rating for Celcuity Inc?
Based on the ratings of Celcuity Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
